object
compar
burden
nosocomi
communityacquir
respiratori
syncyti
viru
rsv
associ
acut
lower
respiratori
tract
infect
alri
adult
pediatr
patient
concomitantli
admit
french
tertiari
hospit
evalu
effect
exist
infect
control
measur
patient
method
prospect
includ
adult
pediatr
patient
admit
necker
hospit
pari
octob
februari
diagnosi
rsvassoci
alri
compar
characterist
alri
patient
communityacquir
versu
nosocomi
infect
group
children
adult
result
communityacquir
nosocomi
rsvassoci
alri
diagnos
inpati
respect
burden
communityacquir
infect
higher
children
adult
versu
total
number
pediatr
adult
inpati
respect
p
versu
total
number
hospit
day
pediatr
adult
unit
respect
p
compar
inpati
communityacquir
alri
nosocomi
infect
frequent
adult
versu
p
subject
least
one
chronic
complex
condit
versu
p
total
number
hospit
day
due
nosocomi
alri
higher
adult
children
versu
p
respiratori
syncyti
viru
rsv
associ
viral
acut
respiratori
infect
caus
hospit
infant
children
rsv
also
burden
healthcar
servic
winter
mortal
older
adult
publish
data
epidemiolog
nosocomi
rsv
infect
still
limit
infant
sever
cours
nosocomi
diseas
describ
especi
subject
comorbid
even
sever
communityacquir
rsv
infect
adult
rsv
acquisit
seem
frequent
nosocomi
healthcarerel
higher
mortal
influenza
viru
infect
howev
best
knowledg
previou
studi
compar
burden
communityacquir
versu
nosocomi
rsvassoci
acut
lower
respiratori
tract
infect
alri
adult
pediatr
patient
concomitantli
admit
hospit
necker
hospit
pari
french
bed
tertiari
hospit
larg
cohort
adult
pediatr
patient
chronic
complex
condit
ccc
regularli
follow
bundl
measur
implement
prevent
nosocomi
rsvassoci
alri
includ
implement
droplet
contact
precaut
symptomat
patient
annual
educ
train
healthcar
personnel
provid
instruct
materi
patient
visitor
recommend
hand
hygien
respiratori
hygienecough
practic
limit
pediatr
visitor
season
outbreak
viral
alri
infant
predispos
develop
sever
rsv
diseas
receiv
passiv
antivir
immun
palivizumab
accord
french
guidelin
final
hospit
recent
partli
rebuilt
includ
high
rate
singlepati
room
may
help
prevent
healthcareassoci
infect
studi
aim
compar
burden
nosocomi
communityacquir
rsvassoci
alri
adult
pediatr
inpati
evalu
effect
infect
control
measur
particip
provid
inform
consent
anonym
use
clinic
biolog
data
biomed
research
paediatr
patient
inform
consent
provid
parentsguardian
studi
review
approv
necker
hospit
institut
review
board
registr
number
registri
assist
publiqu
e
de
pari
perform
prospect
observ
studi
adult
pediatr
patient
admit
necker
hospit
octob
februari
minimum
hospit
stay
day
diagnosi
rsvassoci
alri
rsvinfect
patient
identifi
data
provid
virolog
laboratori
rsvassoci
alri
defin
diagnosi
pneumonia
bronchiol
bronchiti
bronchial
hyperreact
concomit
detect
rsv
upper
respiratori
nosethroat
swab
lower
respiratori
bronchial
aspir
bronchoalveolar
lavag
fluid
sampl
use
pcr
rsvhmpv
marci
letoil
franc
patient
isol
upper
respiratori
tract
infect
without
respiratori
symptom
exclud
analysi
even
rsv
detect
clinic
sampl
rsv
incub
period
may
rang
day
origin
alri
design
possibl
nosocomi
definit
nosocomi
patient
hospit
continu
day
day
onset
respiratori
symptom
respect
alri
consid
communityacquir
patient
whose
symptom
occur
hospit
day
hospit
admiss
clinic
data
collect
includ
age
gender
term
birth
infant
underli
complex
chronic
condit
ccc
previous
defin
laboratoryconfirm
bacteri
viral
cosuprainfect
level
care
requir
admiss
intens
care
unit
icu
ventil
requir
prescript
antibiot
length
hospit
stay
case
nosocomi
infect
length
hospit
stay
onset
symptom
record
death
number
hospit
admiss
total
hospit
day
patient
alri
compar
patient
admit
hospit
studi
period
order
estim
burden
rsv
infect
final
evalu
proport
rsvinfect
subject
adequ
receiv
palivizumabbas
prophylaxi
onset
alri
accord
market
author
palivizumab
european
medicin
agenc
ema
guidelin
french
health
author
guidanc
palivizumab
use
american
academi
pediatr
aap
categor
variabl
appear
frequenc
distribut
nonnorm
distribut
continu
variabl
express
median
interquartil
rang
chisquar
test
fisher
exact
test
use
compar
discret
variabl
wilcoxon
rank
test
use
compar
continu
variabl
patient
communityacquir
versu
nosocomi
alri
p
consid
statist
signific
octob
februari
patient
admit
hospit
diagnos
communityacquir
rsvassoci
alri
characterist
summar
tabl
major
less
month
old
among
born
preterm
least
one
ccc
present
subject
frequent
respiratori
ccc
viral
bacteri
cosuprainfect
document
case
respect
around
one
two
patient
receiv
antibiot
proport
patient
requir
icu
admiss
high
patient
die
children
sever
cardiovascular
ae
respiratori
ccc
die
acut
respiratori
distress
syndrom
compar
patient
admit
hospit
period
time
patient
communityacquir
rsv
infect
account
inpati
total
number
hospit
day
burden
communityacquir
rsv
infect
disproportion
higher
pediatr
adult
patient
versu
total
number
pediatr
adult
inpati
respect
p
versu
total
number
hospit
day
pediatr
adult
unit
respect
p
among
children
communityacquir
rsv
infect
palivizumab
ebas
prophylaxi
given
antivir
prophylaxi
recommend
ema
french
american
guidelin
respect
eleven
patient
diagnos
possibl
n
definit
n
nosocomi
rsvassoci
alri
tabl
almost
half
year
old
older
subject
nosocomi
rsv
infect
least
one
ccc
none
die
rsv
compar
inpati
communityacquir
rsvassoci
alri
nosocomi
infect
frequent
adult
p
subject
least
one
ccc
p
rate
viral
bacteri
cosuprainfect
oxygenventil
requir
icu
admiss
antibiot
treatment
death
differ
inpati
diagnos
communityacquir
versu
nosocomi
infect
howev
length
stay
statist
longer
latter
former
p
compar
patient
admit
hospit
period
time
free
communityacquir
rsvassoci
alri
patient
nosocomi
rsv
alri
account
inpati
total
number
hospit
day
proport
inpati
nosocomi
infect
differ
children
adult
versu
p
howev
total
number
hospit
day
due
nosocomi
rsvinfect
patient
higher
adult
children
versu
p
children
nosocomi
rsvreceiv
palivizumab
ebas
prophylaxi
prior
onset
infect
retrospect
prophylaxi
recommend
children
ema
french
american
guidelin
best
knowledg
report
one
first
studi
evalu
efficaci
bundl
infect
control
measur
prevent
rsv
alri
adult
pediatr
patient
admit
tertiari
hospit
result
regard
communityacquir
rsv
infect
requir
hospit
line
previou
report
subject
hospit
rsv
age
month
especi
month
median
length
hospit
stay
rang
report
previou
pediatr
studi
day
howev
preval
admiss
icu
mortal
rate
higher
previous
describ
highincom
countri
versu
versu
respect
could
explain
high
preval
ccc
popul
children
follow
tertiari
hospit
consequ
admit
communityacquir
rsv
infect
proport
higher
previou
studi
typic
children
hospit
rsvrelat
alribronchiol
underli
medic
condit
thu
epidemiolog
characterist
patient
admit
hospit
communityacquir
rsv
infect
extrapol
french
pediatr
center
studi
burden
rsv
among
communityacquir
alri
requir
hospit
strongli
lower
adult
compar
infant
children
despit
high
preval
ccc
especi
immunodefici
among
adult
follow
center
data
shown
find
suggest
although
rsv
potenti
caus
sever
communityacquir
alri
highrisk
adult
immunocompromis
patient
rsv
infect
seem
rare
requir
hospit
popul
patient
admit
communityacquir
infect
receiv
palivizumabbas
antivir
prophylaxi
prior
onset
infect
howev
retrospect
evalu
medic
file
rsvinfect
inpati
reveal
patient
requir
palivizumab
accord
french
american
guidelin
result
suggest
guidelin
antivir
prophylaxi
appropri
appli
center
patient
admit
rsv
infect
admit
pediatr
icu
fall
recogn
indic
rsv
prophylaxi
recent
report
ghazali
et
al
light
ongo
research
develop
new
costeffect
strategi
rsv
infect
palivizumab
includ
long
act
monoclon
antibodi
vaccin
larger
studi
defin
characterist
patient
hospit
sever
rsv
infect
may
help
rethink
guidelin
rsv
prophylact
strategi
rsv
known
major
nosocomi
hazard
paediatr
ward
especi
case
age
less
month
prematur
chronic
lung
diseas
prematur
previou
studi
describ
rate
nosocomi
rsv
infect
poorer
clinic
outcom
communityacquir
rsv
infect
contrast
result
observ
pediatr
ward
low
rate
nosocomi
rsvrelat
alri
inpati
death
relat
nosocomi
rsv
infect
low
rate
nosocomi
infect
could
relat
multifacet
infect
control
strategi
includ
high
proport
singlepati
room
infect
uninfect
patient
staff
train
repeat
season
viral
epidem
screen
symptomat
patient
isolationcohort
hand
wash
glove
mask
gown
staff
attend
infant
respiratori
symptom
restrict
visitor
interestingli
studi
suggest
efficaci
infect
control
strategi
may
less
effect
adult
pediatr
ward
inde
nosocomi
infect
proportion
frequent
diagnos
adult
communityacquir
alri
p
total
number
hospit
day
due
nosocomi
rsv
infect
higher
adult
children
versu
p
similarli
kestler
et
al
recent
describ
rsv
acquisit
frequent
nosocomi
healthcarerel
adult
flu
season
although
observ
high
rsvrelat
mortal
describ
adult
kestler
describ
longer
length
hospit
stay
case
nosocomi
versu
communityacquir
infect
adult
result
suggest
despit
low
rate
nosocomi
infect
observ
adult
inpati
multifacet
infect
control
strategi
may
reinforc
adult
ward
order
obtain
similar
result
seen
pediatr
unit
low
number
nosocomi
infect
rsv
epidem
could
interest
repeat
studi
sever
success
season
epidem
order
evalu
effect
bundl
measur
larger
popul
studi
five
main
limit
first
rsvrelat
alri
defin
data
provid
virolog
laboratori
rsv
may
screen
signific
proport
patient
alri
studi
may
underestim
real
burden
rsv
infect
center
underestim
may
pronounc
patient
mild
symptom
especi
isol
upper
respiratori
tract
infect
rsv
may
less
frequent
screen
case
sever
infect
howev
potenti
limit
hamper
evalu
efficaci
infect
control
strategi
mainli
aim
prevent
sever
infect
second
although
alri
primarili
attribut
rsv
clinician
patient
describ
studi
exclud
viral
bacteri
coinfect
may
influenc
clinic
outcom
confound
factor
exclud
non
intervent
studi
respiratori
pathogen
may
screen
order
evalu
impact
potenti
bia
prospect
studi
need
systemat
screen
potenti
viral
bacteri
coinfect
third
observ
studi
allow
effect
individu
compon
multicompon
control
measur
assess
similar
observ
done
french
ce
et
al
recent
review
publish
unpublish
literatur
effect
control
measur
prevent
nosocomi
rsv
transmiss
event
howev
similar
prevent
strategi
appli
unit
center
limit
hamper
comparison
efficaci
pediatr
versu
adult
ward
studi
need
order
evalu
extent
complianc
measur
infect
control
bundl
differ
adult
paediatr
popul
nosocomi
infect
may
transmit
healthcar
personnel
visitor
patient
would
interest
differenti
complianc
measur
target
popul
studi
fourth
previous
discuss
high
preval
ccc
among
patient
follow
tertiari
hospit
hamper
extrapol
result
french
hospit
higher
preval
ccc
among
patient
nosocomi
versu
communityacquir
rsv
infect
versu
may
least
partli
explain
longer
length
stay
former
latter
fifth
use
larg
definit
nosocomi
case
pool
possibl
definit
nosocomi
infect
previou
studi
investig
risk
rsv
transmiss
patient
provid
clear
definit
nosocomi
case
variou
cutoff
use
defin
mostli
day
hospit
admiss
chose
wider
definit
nosocomi
case
ie
infect
occur
patient
hospit
continu
day
onset
respiratori
symptom
rsv
incub
period
may
short
day
ii
want
minim
real
burden
rsv
nosocomi
alri
interestingli
although
use
wide
cutoff
burden
high
center
limit
hamper
comparison
burden
nosocomi
infect
pediatr
adult
ward
center
summari
burden
communityacquir
infect
requir
hospit
disproportion
higher
infantschildren
adult
admit
center
nosocomi
rsvassoci
alri
rare
occur
suggest
good
efficaci
multicompon
prevent
strategi
howev
burden
nosocomi
infect
higher
adult
children
suggest
educ
train
healthcar
worker
patient
visitor
risk
nosocomi
respiratori
viral
diseas
reinforc
adult
ward
fact
patient
hospit
communityacquir
nosocomi
rsvassoci
alri
consid
highrisk
ie
requir
immunoprophylaxi
palivizumab
accord
french
american
guidelin
highlight
urgent
need
develop
new
costeffect
antivir
prevent
strategi
order
decreas
burden
rsv
infect
requir
hospit
